TORONTO, April 13 (Reuters) - Aspreva Pharmaceuticals Corp.'s (ASV.TO: Quote, Profile, Research)(ASPV.O: Quote, Profile, Research) shares jumped more than 12 percent on Thursday after it raised its 2006 revenue forecast by 14 percent as it benefits from collaboration with development partner Roche Holding AG (ROG.VX: Quote, Profile, Research).
